Cardiac looping is an early morphogenic process critical for the formation of four-chambered mammalian hearts. To study the roles of signaling pathways, transcription factors (TFs) and genetic networks in the process, we constructed gene co-expression networks and identified gene modules highly activated in individual cardiomyocytes (CMs) at multiple anatomical regions and developmental stages. Function analyses of the module genes uncovered major pathways important for spatiotemporal CM differentiation. Interestingly, about half of the pathways were highly active in cardiomyocytes at outflow tract (OFT) and atrioventricular canal (AVC), including many well-known signaling pathways for cardiac development and several newly identified ones. Most of the OFT-AVC pathways were predicted to be regulated by 66 transcription factors (TFs) actively expressed at the OFT-AVC locations, with the prediction supported by motif enrichment analysis of the TF targets, including 10
Introduction
Prenatal heart development is controlled by evolutionarily conserved genetic networks (Olson, 2006 , Waardenberg, Ramialison et al., 2014 consisting of well-recognized transcription factors (e.g., Gata4, Nkx2-5 and Tbx5) (He, Gu et al., 2014 , Takeuchi, Ohgi et al., 2003 , Zhang, Nomura-Kitabayashi et al., 2014 , signaling pathways (e.g., WNT and BMP) (Afouda, Martin et al., 2008 , Wang, Green et al., 2014 , and dynamic epigenetic networks that are modulated by histone modifications or DNA methylation (Chamberlain, Lin et al., 2014 , Zhang, Wu et al., 2017 , Zhang & Liu, 2015 . These networks ensure the precise establishment of gene expression pattern and concurrent differentiation of cardiovascular cell types in an orderly spatial and temporal manner. However, transcriptional regulatory networks involved in cardiac looping have not been fully deciphered, partially due to the lack of appropriate experimental technology for resolving cellular and developmental heterogeneity.
The introduction of single cell RNA-seq technology has started to overcome this limitation. It revolutionizes the studies of gene regulation in embryonic developments by providing a systematic and highthroughput way to profile the expression of hundreds to thousands of cells simultaneously, resulting in the discovery of new cell types, cell state transitions and functions, as well as gene markers that are associated with unique cells populations and functions (Chen, Chakravarty et al., 2016 , DeLaughter, Bick et al., 2016 , Gladka, Molenaar et al., 2018 , Li, Xu et al., 2016 , Liu, Wang et al., 2017 , See, Tan et al., 2017 , Sereti, Nguyen et al., 2018 , Skelly, Squiers et al., 2018 .
The scRNA-seq data, however, have generally not been fully exploited for addressing the dynamic expression of transcription factors and their cooperative or competitive interactions, even though it is well appreciated that the expression and targets of TFs are fundamental for deciphering the cardiac genetic programs.
In this study, we took a systematic approach to analyze single cell RNAseq (scRNA-seq) data to characterize gene coexpression in differentiating cardiomyocytes at multiple anatomical locations of early cardiac developmental stages, and to investigate their regulation and maintenance by TFs. Our results indicate that the genetic programs for cardiac cell differentiation at the OFT-AVC are extremely complex, involving many critical pathways that are regulated by a significantly large number of TFs. This finding suggests that mutations in the genes regulating OFT-AVC development likely confers a high risk for congenital heart defects (CHD).
Results

Extraction of CM scRNA-seq data
The general approaches of our study are composed of construction of gene coexpression networks from scRNA-seq data, functional enrichment analysis, and prediction of genes and pathways regulated by transcription factors (Fig 1) . Our study started from the scRNA-seq data that were previously obtained from mouse embryonic hearts at embryonic day (E) 8.5
to postnatal day (P) 21 (DeLaughter et al., 2016 . In these two studies, ~3,000 single cells in total were captured for RNAseq from multiple dissected heart zones at different developmental stages. They were composed of multiple cardiac cell types, including endothelial cell (EC), mesenchymal cell (MC), and fibroblast-enriched cell (FE), and CM. To identify CMs from these data, we employed unsupervised clustering methods, similarly to the original reports.
Principal component analysis (PCA) showed that cells from each of the two studies ("dataset 1" and "dataset 2") could be segregated into two parts, confirmed by k-means clustering and t-Distributed Stochastic
Neighbor Embedding (t-SNE) analysis . Based on the expression of known cardiac markers, we were able to identify the CM (expressing
Tnnc1 and Tnni3), EC (expressing Cdh5 and Tek) and MC (expressing Col1a1
and Ptn) clusters (Fig. S1D ). Although we were unable to directly compare our cell clustering result to the original reports because cell type information was not provided in the publically released data (DeLaughter et al., 2016 , the proportion of cells in these clusters and the expression profiles of known markers demonstrated that we have successfully reproduced the original clustering and successfully separated CM from other cardiac cells (Fig. S1D ).
Spatiotemporal-specific transcriptional heterogeneity of CM
As CMs were captured at different developmental stages and anatomical locations, we first studied the contributions of these two factors (time and location) and other technical factors to gene expression variation (see Materials and Methods). We found that the number of expressed genes in individual CMs and anatomical origin explained the most expression variations, followed by developmental stage, but sequencing depth ("counts") was not a main factor (Fig. S2A) . Thus, we considered that the gene expression heterogeneity across CM groups mostly reflected biological difference, consistent with the original reports (DeLaughter et al., 2016 .
Accounting for developmental stages and anatomical locations, the CMs in dataset 1 could be approximately classified into four main clusters ( Fig. 2A) . Excluding outliers (cells in gray in Fig. 2A ), E8.5 CMs appeared as one cluster, while the CMs at E9.5 and E10.5 could be segregated into three clusters based on anatomical locations: "atrial cluster" (including left atrium (LA), right atrium (RA) and AVC), "ventricular cluster" (including left ventricle (LV), left ventricular septum (LS), right ventricle (RV), right ventricular septum (RS)), and "outflow tract cluster" (including E9.5 outflow tract and distal outflow tract (DO)) ( Fig. 2A and Fig. S2B ). We also noticed that E10.5 CMs from proximal outflow tract (PO) showed higher gene expression similarity to RV CMs than E9.5 OFT or E10.5 DO CMs. In summary, the E8.5 to E10.5 CMs can be separated mainly by their temporal (developmental stages) and spatial (anatomic locations) origins that reflect their developmental trajectories.
We next carried out signed weighted gene co-expression network analysis (WGCNA, see Materials and Methods) to define co-expressed gene modules, and studied their relationship to the four main CM clusters. The analysis resulted in 10 gene modules from the 12,792 genes expressed in both datasets ( Fig 2B) , with the module sizes ranging from 63 to 7,524.
Interestingly, the 10 modules contained different proportions of noncoding genes and TFs (Fig S2C and Table S1 
Functional analysis of the WGCNA module genes
We performed GO (Gene Ontology) and pathway analyses to characterize the enriched functions of module genes (see Materials and Methods), focusing on the spatial and temporal modules (Fig 3A and Table S2 ). In the temporal modules, the genes of module 6 (E8.5 CM module) were enriched for function terms in regulation of cell differentiation, positive regulation of gene expression, and response to endogenous stimulus, including module genes Gsk3b, Notch2 and St13 (Fig 3B) , indicating that this gene module is mainly involved in cell differentiation, concordant with the proliferation of early-stage CMs (de la Pompa & Epstein, 2012 , Naito, Akazawa et al., 2005 . The module 5 (E10.5 CM module) genes were enriched in oxidative phosphorylation, electron transport chain, and cardiac muscle contraction signaling known to be highly active in latestage CMs (Chung, Dzeja et al., 2007) . Not only did this module include tropoinin and ryanodine receptor genes, it but also contained a number of important electron transport genes from mitochondrial genome, such as mt-Co2, mt-Co3 and mt-Atp6 (Fig 3B) , indicating distinct enhancement of mitochondrial ATP synthesis along with CM development (Table S2 ).
In contrast, the OFT-AVC module genes (from spatial module 4) were enriched for terms important in cardiac morphogenesis, tube development, cardiovascular system development, and cellular response to growth factor stimulus. These processes have been reported to activate OFT remodeling (de la Pompa & Epstein, 2012 Table S1 ). All these results underlined that our unbiased and systematic function analysis of spatiotemporal module genes uncovered both known and potentially novel signaling pathways in CMs at different anatomical locations or heart looping stages, thus providing molecular profiles for the diverse developmental processes and cellular functions in embryonic CMs.
Modular enrichment of cardiac phenotype-and disease-associated genes
We next addressed how genes associated with different heart phenotypes or diseases were distributed in these gene modules, using the ToppGene and Fisher's exact test (see Materials and Methods) . Surprisingly, the results indicated that even though the modules 1, 2 and 3 contained >80% of the expressed genes, phenotype or disease marker genes were mostly enriched significantly in module 4, 5, 7 and 9 (adjusted p-value < 0.05) ( Fig 3C and Table S3 ). In addition, reanalyzing the published transcriptional profiles of 218 dilated cardiomyopathy patients and controls (Liu, Morley et al., 2015) , we found that 918 of the 1,661 differentially expressed genes (DE genes) were also expressed in the mouse scRNA-seq data, and they were statistically overrepresented in the modules 4, 5, 7, 8 and 9, concordant with our disease and pathway enrichment analyses above ( Fig 3D and Table S2 ). These results support the value of our demarcation of gene modules, as it separated correctly the developmental and disease relevant gene modules from others. In addition, this analysis uncovered the genetic relationship between developmental process and heart abnormalities, thus highlighting the developmental bases of some heart diseases.
Prediction of targets for spatiotemporal transcription factors
After studying the spatiotemporal expression of genes by co-expression networks and functional enrichment analysis, we set out to address the primary goal of current study, how the spatiotemporal expression and networks were regulated and maintained. In total, 186 TFs were present in the five selected modules (temporal-or spatial-specific modules).
103 of them were highly expressed in module 4 (OFT-AVC module), including T-boxes TFs (Tbx2, Tbx3 and Tbx20), Kruppel-like TFs (Klf3, Klf4, Klf6
and Klf7), Gata family (Gata2, Gata3, Gata5 and Gata6) and Id family (Fig 4B and   Table S4 ). Next, we re-analyzed several published microarray gene expression datasets, in which the expression of Hey2, Nr2f2, Tbx3 and Tbx5 in hearts was disrupted (Bonilla-Claudio, Wang et al., 2012 , LunaZurita, Stirnimann et al., 2016 , Russell, Ilg et al., 2015 , Shirvani, Mookanamparambil et al., 2007 , Wu, Kao et al., 2015 . We asked whether the differentially expressed genes upon knockdown or knockout of these TFs were correlated to the targets predicted by our method, using the Chi-square test. The results showed significant correlations, Hey2 (p-
and Tbx5 (p-value = 1.457e-05). Lastly, we repeated the TF-target prediction using the consensus gene network built by both scRNA-seq datasets and found that for 184 of the 186 TFs the predicted targets were reproducible (p-values < 0.05) (Fig 4C and Table S5 , see Materials and Methods). To sum up, all these analyses and results support our TFtarget prediction.
To study TFs with potentially major roles in cardiac-looping stage cardiomyocyte development, we then focused on TFs that are likely "key drivers", central nodes in a co-expression network, (Carcamo-Orive, Hoffman et al., 2017 , Langfelder & Horvath, 2008 , Makinen, Civelek et al., 2014 , Shu, Zhao et al., 2016 , Zhang, Gaiteri et al., 2013 and studied what function pathways they may regulate. Specifically, we selected TFs that were hub genes and actively expressed in individual modules, resulting in 123 TFs ( Fig 4D and We also extended this analysis to heart phenotype-or disease-associated gene sets. The results suggested that ~85% (n = 54) of cardiac TFs were involved in the regulation of gene sets implicated in multiple heart abnormality or diseases (Table S6) , concordant with these TF being defined as "cardiac TFs". Interestingly, the cardiomyopathy-associated genes were overrepresented in the modules 4, 5 and 7 (Table S2) 
Analysis of targets for less studied transcription factors in heart looping
We next studied the 59 less-studied TFs (i.e., associations with abnormal heart phenotypes have not been clearly established), as analyses of their targeted pathways could provide new insights to their potential functions. Compared to the above results for cardiac TFs, the targets of these less-studied TFs, such as Cux1, Etv5, Id2, Irf5, Klf4, Nfil3,  Myrf and Skil, were significantly enriched in many of the same heart developmental terms or processes, supported by similarly high TF-driver scores ( Fig 5C and Fig S3B) . Furthermore, our analysis showed that 45 of the 59 TFs were likely to regulate multiple functional pathways that were enriched in the selected gene modules (Fig 5B and Table S6 Irf5, Id2, Cux1, Myrf, Kdm5b, Grhl1, Arhgap35, Gatad2b, Arid5b, Mga, Peg3, Nfil3, Nr2f1, Ptrf, Camta1, Etv1, Id4 and Nfib (Ahuja, Dogra et al., 2016 , Albert, Schmitz et al., 2013 , Chen, Qin et al., 2015 , Cunnington, Nazari et al., 2009 , da Rosa, Seminotti et al., 2016 , Fletcher, Raza et al., 2015 , Hirose-Yotsuya, Okamoto et al., 2015 , Jongbloed, Vicente-Steijn et al., 2011 , Loirand & Pacaud, 2014 , Monnier, Iche-Torres et al., 2012 , Muller-Borer, Esch et al., 2012 , Nassiri, Liu et al., 2010 , Qi, Yu et al., 2017 , Quaranta, Fell et al., 2018 , Rochais, Dandonneau et al., 2009 , Seneviratne, Edsfeldt et al., 2017 , Shekhar, Lin et al., 2016 , Song, Gao et al., 2018 , Taniguchi, Maruyama et al., 2016 , Theis, Sharpe et al., 2011 , Waldron, Steimle et al., 2016 , Walkowska, Pawlak et al., 2016 , Yaniz-Galende, Roux et al., 2017 . As such, we named these TFs as "literature-based cardiac TFs", to distinguish them from the other "non-cardiac TFs" that do not have known evidence for a cardiac function (Table S5 ). These findings support the biological relevance of our TF-target prediction, and strongly indicates that the set of non-cardiac TFs (n = 24) still have high possibilities to regulate critical pathways in embryonic heart development.
Performing enrichment analysis of TFs' targets for the heart phenotypeor disease-associated gene sets enriched in the five spatiotemporal modules, we found that the targets of the 21 literature-based cardiac or the 24 non-cardiac TFs were significantly overrepresented in multiple gene sets, such as abnormal cardiac outflow tract development, abnormal cardiovascular development, abnormal heart ventricle morphology, and abnormal cardiac muscle contractility (Fig 5D and Fig S3C-D) . To confirm the high expression of the OFT-AVC TFs, we selected 10 less studied TFs for qPCR analysis. The results showed that almost all of these 10 TFs had significantly higher expressions at OFT-AVC than ventricles at E10.5, with some also exhibiting higher expression in E9.5
OFT (Fig 5E) . Further analysis found that the more specific expression patterns they had, the more heart-phenotype gene sets these TFs are involved in, with spearman correlation > 0.7 and p-value < 0.05 at both E9.5 and 10.5 stages (Table S6) .
Expression changes and functional roles of transcription factors in subgroups of atrial or ventricular CMs
The above analyses considered CMs from the same spatial or temporal origin as a "homogenous" group, but CMs in the same group actually showed subtle transcriptional heterogeneity, because CMs from the same anatomical location could be a mixture of cells at multiple developmental states. Therefore, we constructed putative developmental trajectories based on top variable genes (see Materials and Methods) in order to study potential cell state transitions of CM development at atrium, ventricle or outflow tract (including E9.5 OFT, E10.5 DO and PO) (Fig 6A-B and Fig S4A) . The analysis revealed three distinct subgroups ("A", "B" and "C")
in each of the trajectories, largely reflecting the temporal and spatial relationship of CMs at those locations (Fig S4B-G) .
Gene set enrichment analysis (GSEA) indicated that DE genes from pairwise comparisons of the three atrial subgroups were enriched for developmental pathways, such as cell cycle, mRNA processing, protein metabolism, ECM organization, citric acid cycle and gluconeogenesis ( Fig 6C and Table   S7 ). In comparison, the enrichment of ventricular DE genes among the three subgroups was mainly related to myogenesis, oxidative phosphorylation, angiogenesis, epithelial mesenchymal transition, apical junction, and Heme metabolism pathways (Fig 6D and Table S7 ).
Interestingly, only a small number of DE genes (< 60) were found among the subgroups of OFT CMs, even though CMs at this anatomical location were from two embryonic heart stages (E9.5 and E10.5). Mapping the DE genes to the above module genes showed that atrial DE genes were significantly enriched in the modules 4, 5 and 9, while ventricular DE genes were enriched in the module 5 and 10 ( Fig 6E) . Pathway analysis of the overlapped DE genes suggested that both atrial and ventricular DE genes were dramatically overrepresented in the module 5 and enriched in pathways related to muscle system process and muscle contraction ( Fig   6E) , indicating our trajectories could represent developmental states of CMs at different anatomical heart regions.
To further support the importance of TFs in CM development, we examined TFs that were differentially expressed in atrial or ventricular subgroups, and included in the five gene modules. This resulted in 20 DE TFs in the atrial and 10 in the ventricular subgroups ( Fig 6F and Fig   S4D) . Motif analyses showed that the regulatory regions of these atrial DE genes were enriched for 5 TF motifs, Foxp1 (q-value 3.61e-59), Gli3
(q-value 3.07e-04), Htf4 (q-value 4.81e-03), Irf5 (q-value 2.71e-45) and Tbx3 (q-value 2.12e-05) (Fig 6G) . For the ventricular DE genes, Gli3 motif was found (q-value 3.41e-04) (Fig 6G) . The findings strongly supported the regulations of CM differentiation by these TFs that are expressed in a highly spatiotemporal manner.
Discussion
Our study defined spatiotemporal gene co-expression networks from cardiac scRNA-seq data, examined their enrichment of functional pathways and developmental phenotypes, but more importantly investigated TFs' roles in regulating or maintaining functional gene modules that are active in CMs at a specific anatomical location or developmental stage during heart looping stages, from E9.5 to 10.5. Our findings not only confirmed the critical functions of 51 well-known cardiac TFs, like Tboxes gene family, Kruppel-like gene family, Id gene family, and Gata gene family, but also uncovered the potential novel functional roles of 45 less studied TFs. The importance of the latter group of TFs in regulating CM developmental signaling and pathways is supported by the significant enrichment of their targets in heart development and phenotypes (Fig 7) .
Our analysis showed that across heart looping stages many signaling and pathways involved in CM differentiation were enriched in the OFT/AVC module (module 4) and they were predicted to be highly regulated by multiple TFs, and more so than genes in the other modules (Fig 7) . In addition, we found that the proportion of TFs in this module was much higher than those of other modules (Fig S2C) . Integrating the results of function analysis of "cardiac", "literature-based cardiac" and "noncardiac" TFs, our study strongly suggests that the genetic program in differentiating CMs at OFT/AVC is not only regulated by well-studied cardiac TFs, like Tbx2/3, but also under the complex regulation of other 64 TFs (Fig 7) , such as Gli3, Mecom, Loxl2 and Meis2, including additional TFs whose cardiac functions are yet to be addressed. The high expression of the 10 non-cardiac TFs in OFT/AVC was confirmed by qPCR analysis (Fig 5E) . Interestingly, we also found a significant correlation between the non-cardiac TFs' expression patterns and the number of heart phenotypes they involved, with greater specific spatial expression correlated with more phenotypes. Considering all the results described here, we hypothesize that OFT/AVC formation and remodeling is likely the most tightly regulated embryonic heart developmental process. As such, mutations in the genes, especially TFs, important for OFT/AVC development are likely to be the high-risk factors for congenital heart defects. In fact, we analyzed two sets of manually curated CHD-associated genes and found that they were significantly enriched in the OFT-AVC module, with the odds ratios of 2.39 (p-value = 0.001) and 2.35 (p-value = 0.0003) for the 186 CHD genes in the Sifrim et al (Sifrim, Hitz et al., 2016) and the 253 CHD genes in the Jin et al (Jin, Homsy et al., 2017) , respectively. We also analyzed the genes with significantly higher expression in ECs and MCs of OFT-AVC than the ECs/MCs of other locations.
The results indicated that only the group of genes with higher expression in OFT-AVC ECs were significantly enriched for the 253 CHD genes curated by Jin et al, suggesting cell type specificity of our finding.
Although our study has analyzed more than one thousand cardiac CMs from multiple developmental stages and anatomical locations, the number of total cells is relatively small, considering that new scRNA-seq technology allows expression profiling of tens of thousands or even up to millions of cells (Zheng, Terry et al., 2017) . The inclusion of more cells from more time points can certainly improve our results, especially in terms of finding key TFs regulating cell fate commitment and lineage specification. In theory, with all cardiac cells from the same heart being sampled simultaneously, one can also study the TF-regulatory networks and signaling cross-talks among different cardiac cell types, an important matter not addressed in the current study. Finally, it will be necessary to validate our TF-target predictions using scRNA-seq data from wild type hearts and mutant hearts with the expression of selected
TFs compromised, such as previous studies of Nkx2.5 function (DeLaughter et al., 2016 . Nevertheless, the current study has identified key TFs, including not fully characterized ones, that can play important regulatory roles in embryonic heart development.
Materials and Methods
Single cell RNA-seq data
Single cell transcriptional profiles of murine embryonic cardiac cells FBs and 135 other cells.
Data processing and quality control
Raw counts of gene expression data in dataset 1 were directly obtained from the GEO, with read aligned by STAR (2.4) and expression qualified by HTSeq (0.6.1), according to the original authors .
For dataset 2, only fastq files were available in the GNomEx database.
Thus, HISAT2 (Kim, Langmead et al., 2015) was employed to align reads to the mouse genome (GRCm38.79), followed by SAMtool 1.4 (Li, Handsaker et al., 2009 ) to generate alignment files and HTSeq (0.6.1) (Anders, Pyl et al., 2015) to compute read counts. In dataset 1, read counts per cell ranged from 0.55 to 3.3 million, and the number of expressed genes were >4,000. Cells not meeting these criteria were eliminated for subsequent study. Similarly, cells in the dataset 2 were retained if the counts were 0.3 to 2.1 million and >2500 genes were expressed. Furthermore, genes with reads in less than 50% of cells were discarded, resulting 12,792 genes for further analysis, including 1,275 TF genes, 9,694 protein-coding genes, and 1,823 non-coding genes. In both datasets, cells with two or more cell types were deleted, based on our clustering analysis.
Cell clustering, dimension reduction, and trajectory construction
The raw gene count data were processed using packages tidyr 0.8.0 (Wickham & Henry, 2018) , dplyr 0.7.4 (Wickham, Francois et al., 2017) and scater 1.6.1 (McCarthy, Campbell et al., 2017) 1.6 (Kiselev, Kirschner et al., 2017) in R. Ordering cells in a trajectory corresponding to a biological process was also performed by the package monocle 2.6.1 (Trapnell, Cacchiarelli et al., 2014) . We carried this analysis for atrial CMs, using data from LA, RA and AVC of E9.5 and 10.5, ventricular CMs, using data from LS, RS, LV and RV of E9.5 and 10.5, and OFT CMs, using data from OFT, PO and DO. In each case, the top 1,000 most dispersed genes were used in an unsupervised manner. Further, plots in this study were generated by ggplot2 2.2.1 (Wickham, 2016) while heat-map built by pheatmap 1.0.8 (Kolde, 2013) in R.
WGCNA co-expression network
Signed weighted gene co-expression network was built from the expressed genes in dataset 1, using the package WGCNA 1.61 (Langfelder & Horvath, 2008) in R, with the scale-free topology fit index over 0.8. More specifically, we estimated soft-thresholding power and chose 10 to construct gene network in dataset 1. In WGCNA, the adjacencies are used to represent gene connection strengths of gene network. In signed weighted network, Adjancey score = (0.5 * (1 + Cor) )^power
Cor: correlation coefficient, power: soft-thresholding power
From the intramodular connectivity analysis, we defined hub genes as the top connected genes (eigengene-based connectivity, or called signed connectivity, between the gene and module eigengene (kME) ≥ 0.25).
Consensus module analysis
The preservation of the gene modules in dataset 1 were supported by consensus module analysis using the package WGCNA 1.61 (Langfelder, Luo et al., 2011) . The analysis built consensus modules by combining dataset 1 and dataset 2 and then test if the modules generated with dataset 1 alone were preserved in the consensus modules, i.e., if the genes of a given module in dataset 1
were significantly enriched in any consensus module from both datasets, with p-value < 0.05. The Cytoscape (Shannon, Markiel et al., 2003) and
Gephi tools (Bastian, Heymann et al., 2009 ) were employed to visualize gene co-expression networks of the modules; the node size represented connections and the length of edge indicated the strength of the connection.
Differential expression analyses
The differentially expressed genes of different single-cell clusters or subgroups were identified by using package edgeR 3.20.1 (Robinson, McCarthy et al., 2010) in R, with the adjusted p-value < 0.05 as significant. Batch effects were removed when detecting differentially expressed genes, including spatial factor, temporal factor and the condition variable.
Microarray data and DE analysis
The microarray of cardiomyopathy patients were obtained from the GEO (GSE57338) , and the data for Bmp2/4, Hey2, Nr2f2, Tbx3 and Tbx5 were also downloaded from the GEO, with accession numbers GSE34502, GSE6526, GSE63759, GSE73862 and GSE77576, respectively (Bonilla-Claudio et al., 2012 , Luna-Zurita et al., 2016 , Russell et al., 2015 , Shirvani et al., 2007 . All the microarray data were processed using the package oligo 1.42.0 (Carvalho & Irizarry, 2010) in R, and the DE genes was detected using package limma 3.34.5 (Ritchie, Phipson et al., 2015) in R, with adjusted p-value < 0.05.
Gene sets, phenotype and disease-associated enrichment analyses
Pathway (GO, KEGG and Reactome) (Fabregat, Jupe et al., 2018 , Kanehisa, Furumichi et al., 2017 , The Gene Ontology, 2017 and gene set enrichment analyses were performed using the ToppGene suite (Chen, Bardes et al., 2009 ) and GSEA 3.0 (Subramanian, Tamayo et al., 2005) , respectively, with FDR < 0.05 as a cutoff in David and FDR < 0.1 in GSEA. Phenotype and disease-associated enrichment analyses were also carried out using the ToppGene suite, with FDR < 0.05. The enriched phenotype and disease terms (IDs) from the ToppGene were cross compared to the disease category information in the MGI (Mouse Genome Informatics) (Dickinson, Flenniken et al., 2016) , IMPC (International Mouse Phenotyping Consortium) (Collins, Finnell et al., 2007) and DisGeNET (Pinero, Bravo et al., 2017) databases to retrieve terms related to cardiovascular systems, heart phenotypes and cardiac diseases, resulting in 395 gene sets associated with abnormal heart phenotypes and 99 gene sets linked to cardiac diseases.
The MGI: http://www.mousemine.org/mousemine/begin.do
The IMPC: http://www.mousephenotype.org/data/search/mp?kw=*
The DisGeNET: http://www.disgenet.org/web/DisGeNET/menu/browser?1.
Cardiac, literature-based and non-cardiac TFs
To uncover potentially novel TFs involved in regulating cardiac development, we used heart phenotype-or disease-associated gene sets from the MGI, IMPC and DisGeNET databases, and literature search to separate TFs into three groups. "Cardiac TFs" were the TFs that have been associated (i.e., annotated) within any heart-phenotype gene sets from the three databases. The rest were further classified either as "literature-based cardiac TFs," if there is a literature support for a function in heart development, or otherwise as "non-cardiac TFs", to indicate their unknown roles in cardiac development or function.
TF-target analysis
123 TFs considered as key drivers were selected by these criteria, 1) a member of the five selected modules (4, 5, 6, 7, 8) , 2) high expression (average cpm > 1 in the given module), and 3) a hub gene in the module.
To predict the TF-target relationship, we used the adjacency scores computed by WGCNA. Considered all the genes (n = 12,792) in the signed weighted gene co-expression network of dataset 1, the top 20% adjacency values were ≥ 0.0017. For a TF, any gene with an adjacency ≥ 0.0017 was considered to be a candidate target of this TF. In TF-target preservation analysis, this cutoff (adjacency ≥ 0.0017) was also applied to define TF-targets in consensus gene co-expression networks from both datasets.
Because TF-target analysis was based on the top adjacency, a TF and its targets might be in different modules, and our TF-target consensus analysis included all the targets. On the other hand, to investigate the regulatory roles of TFs in the spatiotemporal modules, our enrichment analysis of a TF's targets discarded the targets which were in different module from the TF.
TF-driver score
To investigate and predict the effects of a TF on a given pathway, GO term or heart phenotype gene set, we imported an approach, termed "key driver analysis", which estimate the functions of a key driver by enrichment analysis of the driver's targets. The targets of 123 TFs were qualified by this approach, and we scored the results by the following formula, Score = T = /T ?@?AB ME = /ME ?@?AB T s : TF targets in the pathway; T total : total TF's targets; ME s : the overrepresenting module genes in the pathway; ME total : total module genes For each TF, we first investigated its module and the pathways, GO terms and gene sets enriched in this module, then performed the enrichment analysis of this TF's targets, finally selected the overlap between the two enrichment results. After determining the pathways, GO terms and gene sets, we detected TF-driver scores of individual TFs to explore their potential functions.
DNA motif enrichment analysis. To obtain regulatory regions of mouse genes, we downloaded murine heart E10.5 H3K27ac ChIP-seq data from the ENCODE project (DunhamKundaje et al., 2012) (ENCSR582SPN) . The peaks, corresponding to either promoters or enhances, from -50 kb to +50 kb of the transcription start site of a gene was used for motif analysis. The enrichment of TF binding motifs were performed using the AME 4.12.0 (McLeay & Bailey, 2010) of MEME suite (FDR < 0.05). Motif visualization and similarity analysis were carried out using package motifStack 1.22.0 (Ou, Wolfe et al., 2018) and MotIV 1.34.0 (Mercier & Gottardo, 2014) 
RNA extraction and qPCR
The hearts were isolated from E9.5 and E10.5 embryos and separated into three parts including atrioventricular canal (AVC), outflow tract (OFT) and ventricle. Tissues from four hearts were pooled as one sample and subjected to total RNAs extraction using Trizol (Life technology) according to the manufacture's manual. First strand cDNA was synthesized using the Superscript IV Reverse Transcriptase Kit (Life technology). qPCR was performed using the Power SYBR Green PCR Master Mix (Life technology). Gene specific primers were used (Table S8) . The relative expression level of genes was normalized to the expression level of Gapdh and calculated using the 2-ΔΔCTmethod. Biological repeats were performed using four different samples. Student's t-Test was used for comparison between groups and the probability (p) value <0.05 was considered as significant.
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